Elfun Trusts Buys Lowe's Inc, Biomarin Pharmaceutical Inc, Facebook Inc, Sells Allergan PLC, Gilead Sciences Inc, Charter Communications Inc

• New Purchases: LOW, BMRN, TXN, MDLZ,
• Added Positions: FB, BSX, ELAN, MRK, SRE, HON, GLW, CRM, LYFT, FIS, URI,
• Reduced Positions: GILD, CHTR, AAPL, MSFT, V, AMT, UNH, VRTX, JPM, CME, SPGI, NOW,
• Sold Out: AGN, PFE,

For the details of David Carlson's stock buys and sells, go to https://www.gurufocus.com/guru/david+carlson/current-portfolio/portfolio

1. Microsoft Corp (MSFT) - 978,135 shares, 6.47% of the total portfolio. Shares reduced by 15.31%
2. Amazon.com Inc (AMZN) - 62,900 shares, 5.15% of the total portfolio.
3. Visa Inc (V) - 692,300 shares, 4.68% of the total portfolio. Shares reduced by 17.58%
4. JPMorgan Chase & Co (JPM) - 1,110,821 shares, 4.20% of the total portfolio. Shares reduced by 5.06%
5. Alphabet Inc (GOOG) - 83,000 shares, 4.05% of the total portfolio.

Elfun Trusts initiated holding in Lowe's Companies Inc. The purchase prices were between $65.02 and $126.57, with an estimated average price of $109.88. The stock is now traded at around $104.16. The impact to a portfolio due to this purchase was 2.26%. The holding were 625,949 shares as of .

Elfun Trusts initiated holding in Biomarin Pharmaceutical Inc. The purchase prices were between $71.37 and $96.85, with an estimated average price of $86.22. The stock is now traded at around $92.03. The impact to a portfolio due to this purchase was 1.44%. The holding were 406,691 shares as of .

Elfun Trusts initiated holding in Texas Instruments Inc. The purchase prices were between $93.5 and $134.25, with an estimated average price of $120.51. The stock is now traded at around $115.92. The impact to a portfolio due to this purchase was 1.21%. The holding were 289,561 shares as of .

Elfun Trusts initiated holding in Mondelez International Inc. The purchase prices were between $41.93 and $59.68, with an estimated average price of $54.28. The stock is now traded at around $50.98. The impact to a portfolio due to this purchase was 0.77%. The holding were 367,883 shares as of .

Elfun Trusts added to a holding in Facebook Inc by 61.27%. The purchase prices were between $146.01 and $223.23, with an estimated average price of $196.62. The stock is now traded at around $202.66. The impact to a portfolio due to this purchase was 1.28%. The holding were 480,092 shares as of .

Elfun Trusts added to a holding in Boston Scientific Corp by 39.29%. The purchase prices were between $25.83 and $45.71, with an estimated average price of $39.29. The stock is now traded at around $37.38. The impact to a portfolio due to this purchase was 0.71%. The holding were 1,833,003 shares as of .

Elfun Trusts added to a holding in Elanco Animal Health Inc by 67.42%. The purchase prices were between $16.68 and $32.25, with an estimated average price of $27.52. The stock is now traded at around $24.69. The impact to a portfolio due to this purchase was 0.7%. The holding were 1,845,860 shares as of .

Elfun Trusts added to a holding in Merck & Co Inc by 27.02%. The purchase prices were between $66.4 and $92.04, with an estimated average price of $82.63. The stock is now traded at around $79.30. The impact to a portfolio due to this purchase was 0.59%. The holding were 862,576 shares as of .

Elfun Trusts added to a holding in Sempra Energy by 118.73%. The purchase prices were between $88.62 and $161.13, with an estimated average price of $142.55. The stock is now traded at around $123.78. The impact to a portfolio due to this purchase was 0.56%. The holding were 217,197 shares as of .

Elfun Trusts added to a holding in Corning Inc by 27.11%. The purchase prices were between $17.75 and $30.4, with an estimated average price of $26.23. The stock is now traded at around $21.96. The impact to a portfolio due to this purchase was 0.23%. The holding were 1,271,100 shares as of .

Elfun Trusts sold out a holding in Allergan PLC. The sale prices were between $164.7 and $202.1, with an estimated average price of $188.56.

Elfun Trusts sold out a holding in Pfizer Inc. The sale prices were between $28.49 and $40.71, with an estimated average price of $36.04.

Elfun Trusts reduced to a holding in Gilead Sciences Inc by 78.96%. The sale prices were between $62.63 and $80.22, with an estimated average price of $68.92. The stock is now traded at around $82.18. The impact to a portfolio due to this sale was -1.22%. Elfun Trusts still held 145,375 shares as of .

Elfun Trusts reduced to a holding in Charter Communications Inc by 32.88%. The sale prices were between $371.7 and $542.46, with an estimated average price of $489.92. The stock is now traded at around $496.45. The impact to a portfolio due to this sale was -1.09%. Elfun Trusts still held 132,900 shares as of .

Elfun Trusts reduced to a holding in Apple Inc by 23.68%. The sale prices were between $224.37 and $327.2, with an estimated average price of $295.01. The stock is now traded at around $290.94. The impact to a portfolio due to this sale was -1.07%. Elfun Trusts still held 340,300 shares as of .

Elfun Trusts reduced to a holding in American Tower Corp by 20.11%. The sale prices were between $179.09 and $256.9, with an estimated average price of $233.06. The stock is now traded at around $236.93. The impact to a portfolio due to this sale was -0.54%. Elfun Trusts still held 271,629 shares as of .